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Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
The effects of' angiotensin II and norepinephrine on afferent arterioles
in the rat. Perfusion—fixation and vascular casting were used to deter-
mine if angiotensin II and norepinephrine cause constriction of afferent
arterioles, and if so, whether or not the constriction is principally
attributable to a secondary (autoregulatory) response to elevated pres-
sure in the renal circulation. Rats were divided into six groups, and
were given five minute infusions of angiotensin II, norepinephrine, or
normal saline before perfusion—fixation. Angiotensin II infusions were
given to animals in Groups 1 and 2; in Group 1 the renal circulation was
exposed to elevated blood pressure, but in Group 2 intrarenal pressure
was maintained at normal levels by partial ligation of the aorta above
the renal arteries. Groups 3 and 4 were comparable to Groups 1 and 2
respectively, except that norepinephrine was infused instead of angio-
tensin II. Groups 5 and 6 received infusions of normal saline instead of
vasopressor substances. In Group 5, renal vessels were perfusion—fixed
at elevated pressures, while in Group 6 renal vessels were perfu-
sion—fixed at normal pressures. Scanning electron microscopy was used
to examine and measure vascular casts of 40 to 50 afferent arterioles
from each rat. In Groups 1 through 4, casts of afferent arterioles showed
severe, focal, and irregularly distributed constriction. In Groups 5 and
6 there was no qualitative evidence of afferent arteriolar constriction or
irregularities in vessel caliber. Vessel diameter measurements were
significantly smaller in Groups I to 4 when compared to Groups 5 and
6, and arteriolar constriction in the juxtamedullary and cortical regions
was quantitatively comparable in Groups 1 to 4. Arteriolar diameters in
Group 5 were somewhat, but not significantly smaller than those in
Group 6, suggesting that perfusion—fixation at elevated pressure alone
may have made a minor contribution to afferent vasoconstriction.
However, this constriction was clearly not of the same pattern or
magnitude as that produced by angiotensin II or norepinephrine infu-
sions. The results indicate that both angiotensin II and norepinephrine
cause severe, focal constriction of afferent arterioles, and that this
constriction cannot be attributed primarily to a pressure—induced auto-
regulatory response in the renal vasculature.
Although numerous studies have examined the effects of
vasoconstrictor substances such as angiotensin II and norepi-
nephrine on intrarenal hemodynamics, it remains unclear
whether these substances act primarily on preglomerular or on
postglomerular vessels. There seems to be little doubt that both
angiotensin II and norepinephrine produce constriction of ef-
ferent (postglomerular) arterioles; indeed, some investigators
believe that the efferent arteriole is the principal or exclusive
site of action of these vasoconstrictors, especially angiotensin
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II[1, 2]. The effect of vasoconstrictors on afferent (preglomer-
ular) vessels is, however, less certain. Some studies have
suggested that angiotensin II acts directly on afferent vessels to
cause vasoconstriction [3—7]; others have indicated that angio-
tensin II causes only minimal afferent vasoconstriction or that
vasoconstriction occurs secondarily as an autoregulatory (pos-
sibly myogenic) response to elevated pressure in the renal
circulation [8—19]. Similarly, norepinephrine has been shown to
have either a direct vasoconstrictive effect on afferent renal
vessels in some experiments [5, 13, 19, 20], or an indirect effect,
related to an autoregulatory response to increased blood pres-
sure, in others [8].
Because there is no clear consensus about the response of
afferent arterioles to angiotensin II and norepinephrine, the
present study was undertaken to specifically examine afferent
vessels, using a perfusion—fixation and vascular casting tech-
nique [21]. The intent was to determine: 1) if angiotensin II and
norepinephrine produce afferent arteriolar constriction when
both systemic and renal blood pressures are elevated; 2) if these
agents constrict afferent arterioles when pressure in the renal
circulation is maintained at a normal level (by partial ligation of
the aorta above the renal arteries); 3) if afferent arteriolar
constriction occurs when intrarenal arteries are perfusion—fixed
at increased pressure without the use of vasoconstrictive
agents; and 4) if cortical and juxtamedullary afferent arterioles
respond differently to changes in pressure in the renal circula-
tion.
Methods
Thirty male Wistar rats (Charles River Laboratories, Wil-
mington, Massachussetts, USA) weighing 200 to 220 g were
used. All animals were anesthetized with pentobarbital (40
mg/kg body wt, Harvey Laboratories, Philadelphia, Pennsylva-
nia, USA) before operative procedures were begun. The left
jugular vein was cannulated with a PE-20 catheter for infusion
of angiotensin II, norepinephrine, or normal saline. Another
catheter (PE-50) was inserted into the right carotid artery and
connected to a pressure transducer (Statham Instruments Divi-
sion, Gould Inc., Oxnard, California, USA) for direct recording
of arterial pressure on a Gould 2200 physiograph (Gould, Inc.,
Instruments Division, Cleveland, Ohio, USA). The abdomen
was opened and the abdominal aorta cannulated with a PE-60
catheter, inserted proximal to the aortic bifurcation and distal to
the renal arteries in a retrograde direction. The aortic catheter
was attached to one outlet of a three way stopcock. A second
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outlet of the stopcock was connected to a Statham pressure
transducer for direct recording of arterial pressure in the aorta,
and a third outlet to a Masterfiex pump (Cole—Parmer Instru-
ment Company, Chicago, Illinois, USA) for perfusion—fixation
of the abdominal vessels. Outlets connecting the aortic catheter
and aortic pressure transducer remained open at all times, thus
providing a continuous record of pressure in the aorta. The
outlet to the pump apparatus remained closed until perfu-
sion—fixation was begun; at that time, perfusion—fixation pres-
sure was carefully controlled by observing readings taken from
the aortic pressure transducer.
The rats were divided into six groups.
Angiotensin lI-treated rats with renal vessels exposed to high
blood pressure
The five rats in this group first underwent a sham operation in
which a length of 3-0 silk suture was placed around the
abdominal aorta proximal to the renal arteries, but was not tied.
Angiotensin II (CIBA, Summit, New Jersey, USA) was infused
into the left jugular vein using a Sage pump (Orion Research,
Inc., Cambridge, Massachusetts, USA) at a rate of 0.2 g (0.05
ml)/kg body wt/min for five minutes. During this time, the
increase in arterial pressure was recorded from catheters in
both the right carotid artery and the aorta. After five minutes of
angiotensin II infusion, the renal and abdominal vessels were
immediately perfusion—fixed with 1.5% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.4, room temperature), delivered
through the aortic catheter. The vessels were perfusion—fixed at
exactly the same pressure that was recorded in the aorta before
perfusion; this was documented by continuous recording from
the aortic pressure transducer. At the onset of perfusion—fixa-
tion, the left renal vein was punctured to provide an exit for the
perfusate. Perfusion—fixation was continued for approximately
ten minutes.
Angiotensin Il-treated rats with renal vessels exposed to
normal blood pressure
In these five rats, a 3-0 silk suture was placed around the
abdominal aorta proximal to the renal arteries. While blood
pressure readings were taken from both the carotid artery and
aorta, angiotensin II was infused into the left jugular vein (0.2
jg (0.05 ml)/kg body wtlmin). At the onset of infusion, the
suture above the renal arteries was tightened to partially
constrict the aorta, thereby maintaining the normal (baseline)
blood pressure in the aorta and renal arteries distal to the
suture, as verified by pressure tracings taken from the aortic
catheter. After five minutes of angiotensin II infusion, the renal
and abdominal vessels were perfusion—fixed at normal pres-
sure—that is, the pressure recorded from the aortic catheter—
as described for animals in Group 1.
Norepinephrine—trea ted rats with renal vessels exposed to
high blood pressure
In this group of five rats, a ligature was placed around the
proximal abdominal aorta but was not tied. The rats then
received a five minute i.v. infusion of norepinephrine (Sigma
Chemical Company, St. Louis, Missouri, USA) at a rate of 2 g
(0.05 ml)/kg!min, a dose that produced increases in blood
pressure comparable to those achieved by angiotensin II infu-
sions. The resulting increase in blood pressure was recorded
from catheters in the carotid artery and aorta. After five
minutes of norepinephrine infusion, perfusion—fixation of the
renal and abdominal vessels was begun; the vessels were
perfused at the elevated pressure recorded from the aorta
during norepinephrine infusion.
Norepinephrine—trea ted rats with renal vessels exposed to
normal blood pressure
Five rats were used in this group. A ligature was first placed
around the abdominal aorta proximal to the renal arteries.
During i.v. norepinephrine infusion (2 g(Q.05ml)/kg/min),
blood pressure recordings were obtained from both the carotid
artery and aorta. At the onset of norcpinephrine infusion, the
aortic ligature was tightened sufficiently to maintain a normal
(baseline) blood pressure reading in the abdominal aorta distal
to the ligature. After five minutes of norepinephrine infusion,
the renal and abdominal vessels were perfusion—fixed at normal
(baseline) pressure as verified by pressure tracings from the
aortic catheter.
Saline—treated rats with renal vessels perfusion—fixed at high
pressure
In this group, animals received five—minute i.v. infusion of
normal saline rather than vasopressor agents, after which the
renal vessels were immediately perfused with fixative at ele-
vated pressures comparable to those achieved in Groups I and
3. Animals in Group 5 served as controls for Groups 1 and 3, in
order to determine if perfusion of fixative at high pressure per se
produced changes in vessel diameter. The five rats in this group
first underwent sham ligation of the aorta proximal to the renal
arteries as described for Group I. An infusion of normal (0.9%)
saline was given through the left jugular vein at a rate of 0,05
mI/kg/mm for five minutes. The renal and abdominal vessels
were then fixed by immediate perfusion of 1.5% glutaraldehyde
at an increased pressure (40 to 50 mm Hg over baseline
readings) as verified by tracings recorded from the aortic
catheter.
Saline—treated rats with renal vessels perfusion—fixed at
normal pressure
In this group of five rats, a suture was placed around the
abdominal aorta proximal to the renal arteries, but was not tied.
Normal (0.9%) saline was infused into the jugular vein at a rate
of 0.05 mi/kg/mm for five minutes. Blood pressure was recorded
from catheters in the carotid artery and aorta during this period.
The renal and abdominal vessels were then immediately
perfusion—fixed at normal (baseline) pressure as determined by
pressure tracings obtained from the aortic catheter.
For all groups, vascular casts were prepared by mixing
Batson's #17 casting resin (Polysciences, Warrington, Pennsyl-
vania, USA) in the proportion of 4: 1:0.1 for monomer, cata-
lyst, and promoter, respectively. Following the perfusion—fixa-
tion procedure, the casting resin was injected into the aortic
catheter in each animal using a pressure gauge to ensure that
injection was performed at the same pressure used for perfu-
sion—fixation. After allowing the casting resin to harden for one
hour, the left kidney was removed, placed in a beaker of warm
(60C) water for two hours, then transferred to a beaker of
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Table 1. Mean arterial pressuresa
N = 5
Substance
infused
MAP before
infusion
(carotid artery)
MAP after
infusion
(carotid artery)
Perfusion-fixation
pressure (aorta)
Group I All 96.4 2.7 150.6 4.7k' 152.4 5.S'
Group 2
Group 3
All
NE
97.6 1.7
96.6 1.1
150.4 1,2b
147.8 3.1"
96.0 1.2
148.6 3.8"
Group 4 NE 96.8 2.7 147.6 2.3'-' 95.6 1.5
Group 5 Normal
saline
94.6 2.3 94.8 5.0 146.4 4,0b
Group 6 Normal
saline
95.2 1.7 94.6 2.6 94.4 3.0
a Abbreviations are: All, angiotensin II; and NE, norepinephrine. All values are means expressed in mm Hg 5EM.
b MAP significantly greater than corresponding baseline MAP (P < 0.005)
warm 40% KOH, and placed in an oven for overnight digestion
of the tissue.
The casts of the renal vessels were rinsed in distilled water,
air dried, and trimmed for mounting on aluminum stubs covered
with copper tape. The casts were transferred to a sputter coater
(Technics, Alexandria, Virginia, USA) for coating with gold—.
palladium for 90 seconds at 1.0 mvolts. A JEOL JSM-35
scanning electron microscope (JEOL, Tokyo, Japan) (SEM)
was used for examining and photographing the casts.
Casts of the afferent arterioles were examined in the SEM at
400x, using an accelerating voltage of 15 kV and a working
distance of 15 mm. Images of the casts were centered on the
screen of the cathode ray tube to avoid possible distortion near
the edges of the screen. From each rat 40 to 50 casts of afferent
arterioles were photographed using PXP 120 film (Kodak,
Rochester, New York, USA). Two criteria were used in select-
ing vessels for photography. First, each arteriole photographed
was approximately horizontal in position (that is, its entire
length remained in sharp focus) to minimize perspective error.
Second, photographs were taken only of afferent vessels that
were fully injected with casting resin, as evidenced by injection
of at least a portion of the glomerular capillary loops attached to
each arteriole. During photography, arterioles in a juxtame-
dullary location were coded for later analysis to distinguish
them from arterioles in the mid and superficial cortex. Juxta-
medullary arterioles were considered to be those vessels
branching from arcuate arteries or branching from interlobular
arteries near their point of origin.
Photographic prints of each arteriole were obtained by en-
larging negatives 2.5x. The prints were then placed on a
digitizing pad (Summagraphics, Fairfield, Connecticut, USA)
and a cursor was used to trace vessel outlines; values for area,
length, maximum diameter, and minimum diameter were ob-
tained for each vessel using an Image 80 image analysis system
(Laboratory Computer Systems, Cambridge, Massachusetts,
USA). Values for mean diameter were calculated by dividing
area by length. To accurately convert these figures into units of
microns, photographs of a 400 mesh Cu-Al standard calibration
grid (F. F. Fullam, Schenectady, New York, USA) were taken
at 400x, enlarged 2.5x in final prints, and measured on the
digitizing pad to derive a conversion factor.
Data were tabulated and analyzed on a Compaq Deskpro
computer (Compaq Computer Corporation, Houston, Texas,
USA). Analysis of variance was used to test for significant
differences in blood pressure among the six groups; to compare
blood pressure values within each group, Student's t-test was
used. Morphometric data were tabulated to determine average
values for the length, maximum diameter, minimum diameter,
and mean diameter of the 40 to 50 arteriolar casts from each rat,
and these values were used to calculate means for each group of
five rats. Means for each group were calculated for vessels in all
regions and then for juxtamedullary and cortical arterioles
separately. Morphometric data from the six groups were first
submitted to analysis of variance; then multiple t-tests were
performed on paired groups using the Bonferroni method [221,
for which a P value of 0.00833 was required for statistical
significance. Cortical and juxtamedullary data within each
group were compared using Student's t-test. All values were
expressed as means SEM.
Results
Mean arterial pressures (MAPs) SEM for each of the six
groups are presented in Table 1. There were no significant
differences in average baseline (pre-infusion) MAPs among the
six groups. Angiotensin II infusions produced slightly higher
MAPs in Groups 1 and 2 than did norepinephrine infusions in
Groups 3 and 4 (as recorded from the carotid artery) but these
differences were not significant. During angiotensin II infusion,
average MAPs for Groups 1 and 2 rose to 150.6 4.7 and 150.4
1.2 mm Hg, respectively, in readings taken from the carotid
artery, and these pressures were significantly higher than cor-
responding baseline MAPs (P < 0.005). In Groups 3 and 4,
norepinephrine infusion produced an increase in MAP to 147.8
3.1 and 147.6 2.3 mm Hg (carotid artery recordings),
respectively; these values were significantly greater (P < 0.005)
than the corresponding baseline MAPs. In the Group 5 animals,
the renal vessels were perfusion—fixed at a pressure of 146.4
4.0 mm Hg (readings taken from the aorta), which was signifi-
cantly greater (P < 0.005) than the baseline MAP for this group
and comparable to the pressures used for perfusion—fixation in
Groups 1 and 3. Renal vessels in Group 6 were perfusion—fixed
at 94.4 3.0 mm Hg (abdominal aorta recordings) which was
not significantly different from corresponding baseline pres-
sures in this group or from perfusion—fixation pressures used in
Groups 2 and 4.
Scanning electron microscopy of the vascular casts revealed
distinct differences between the groups that were treated with
vasopressors (Groups I to 4) and those that were not (Groups 5
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and 6). In the angiotensin IT-treated animals (Groups 1 and 2),
the most characteristic feature was severe constriction of
afferent arterioles, which was typically irregular, occurring in a
patchy or localized fashion along the length of the vessels. In
Group 1, for example, the afferent arterioles displayed regions
of severe focal constriction, while other regions were either
unconstricted or less severely constricted (Fig. l) this was true
for arterioles located in the mid and outer cortex (Fig. lA) as
well as those in the juxtamcdullary region (Fig. 1B). A similar
pattern of patchy, irregular constriction was seen in afferent
arterioles from Group 2, including those in the cortex (Fig. 2A)
and juxtamedullary locations (Fig. 2B). There were no obvious
qualitative differences in the arteriolar constriction pattern
observed in the two angiotensin 11-treated groups.
Arteriolar casts from norepinephrine—treated animals
(Groups 3 and 4) showed constriction patterns similar to those
found in angiotensin 11-treated rats. Constriction was typically
focal and irregularly distributed in afferent arterioles located in
the mid and outer cortex (Figs. 3A and 4A) and in the juxtame-
dullary region (Figs. 3B and 4B), with no obvious differences in
Fig. 1. Casts of afferent arterioles from an
angiotensin 1I-treted rat with renal vessels
exposed to high blood pressure (Group I). A
is from the cortex and B is from the
juxtamedullary region. A focal and irregular
pattern of arteriolar constriction is evident.
(800x)
the pattern or degree of constriction in the two regions. The
patterns of constriction were similar in the rats from Group 3
(Figs. 3A and 3B) and Group 4 (Fig. 4A and 4B) and no distinct
differences were noted between the two groups.
In Group 5 rats, the casts of afferent arterioles were typically
uniform in caliber with no obvious focal or diffuse constriction,
in both the cortical (Fig. 5A) and juxtamedullary regions (Fig.
5B). Arteriolar casts from Group 6 animals also showed no
irregularities in caliber, and vessels from cortical (Fig. 6A) and
juxtamedullary regions (Fig. bB) appeared qualitatively similar
to those observed in Group 5.
Morphometric data for afferent arterioles from the six groups
(including both cortical and juxtamedullary vessels) are pre-
sented in Table 2. There were no significant differences in
length or maximum diameter among the various groups. Al-
though values for maximum diameter were somewhat smaller in
the angiotensin lI-treated animals (16.56 : 0.32 in Group 1 and
16.73 0.3 2 in Group 2), they were not significantly different
from corresponding values in the other groups. In the angioten-
sin Il-treated groups (1 and 2) and norepinephrine—treated
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Fig. 2. Casts of afferent arterioles from an
angiotensin 11-treated rat with renal vessels
exposed to normal blood pressure (Group 2).
A is from the cortex, and B is from the
juxtamedullary region. Similar patterns of
focal, intermittent constriction are shown.
(800x)
groups (3 and 4), values for minimum diameter and mean
diameter were significantly lower than corresponding values in
Group 5 or Group 6 (P < 0.005, Bonferroni method for multiple
t-tests). There were, however, no significant differences be-
tween any of the pairs in Groups 1 to 4 for the minimum and
mean diameter. Maximum, minimum, and mean diameter mea-
surements in Group 5 were somewhat smaller than those in
Group 6, but these differences were not statistically significant.
Table 3 presents measurements of afferent arterioles from the
mid and outer cortex in the six groups; data for juxtamedullary
arterioles are excluded. There were no significant differences in
length or maximum diameter among the six groups. However,
values for minimum diameter and mean diameter were signifi-
cantly lower (P < 0.005) in all four groups treated with
vasopressors (Groups 1 to 4) when compared to either Group S
or Group 6. There were no significant differences among the
various pairs in Groups 1 through 4 for minimum and mean
diameter, however. Maximum, minimum and mean diameters
were somewhat smaller in Group 5 compared to those in Group
6, but these were not statistically significant differences.
Morphometric data for juxtamedullary afferent arterioles are
compiled in Table 4. Mean values for length and maximum
diameter were not significantly different among the six groups.
In Groups 1 to 4, minimum diameters and mean diameters were
significantly lower (P <0.005) than those in Group 5 or Group
6, but these values were not significantly different among the
various pairs in the four groups. Maximum, minimum, and
mean diameters were somewhat smaller in Group 5 than in
Group 6, but not significantly so. When data from juxtame-
dullary and cortical arterioles were compared within groups,
the values for mean length were found to be significantly higher
(P < 0.005) in juxtamedullary arterioles in all six groups. None
of the other comparisons of cortical and juxtamedullary data
within groups revealed significant differences, however.
Discussion
The effects of angiotensin II and norepinephrine on afferent
and efferent arterioles in the kidney have been examined in a
host of studies, using a variety of animal species and tech-
niques, in an attempt to understand how these agents affect the
r
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regulation of renal blood flow and filtration. There is now
almost universal agreement, based on a large body of evidence,
that both angiotensin II and norepincphrine act directly on
efferent arterioles to produce constriction [1, 21. For afferent
arterioles, however, the evidence is less certain, and often
contradictory. Some studies suggest that angiotensin II and
norepinephrine constrict afferent arterioles by direct action
(presumably acting through specific receptors on these vessels);
others suggest that these agents cause minimal afferent auto-
regulatory (possibly myogenic) response to increases in sys-
temic and renal circulation pressure.
In the rat, micropuncture techniques have been used to study
the effects of angiotensin II or afferent vessels, and the evidence
is conflicting, Myers, Deen and Brenncr 181 found that i.v.
infusion of angiotensin II in the rat produced a significant
increase in afferent arteriolar resistance only when there was a
concomitant increase in systemic and renal pressure; partial
constriction of the aorta above the renal arteries effectively
prevented a significant increase in afferent resistance. Ichi-
kawa, Mielc and Brenner [9j showed that infusion of angioten-
Fig. 3. Casts of afferent arterioles from a
norepinephrine—treated rat with renal vessels
exposed to high blood pressure (Group 3). A
is from the cortex, and B is from the
juxtamedullary region. Focal and irregularly
distributed constriction are displayed. (800x)
sin II directly into the renal artery increased only efferent (not
afferent) resistance when there was no accompanying elevation
of systemic blood pressure. However, in micropuncture studies
by Blantz, Konnen and Tucker 131, infusion of an angiotensin II
analogue (Asn-l, Val-5 angiotensin II) was found to increase
afferent resistance even when there was no attendant elevation
of systemic blood pressure. A later report from the same
laboratory [41 demonstrated that when angiotensin II was given
simultaneously with saralasin (an angiotensin II antagonist),
afferent arteriolar resistance increased even though blood pres-
sure remained normal.
In rats, techniques other than micropuncture have also pro-
duced conflicting evidence. Hsu, Kurtz and Slavicek 1101, using
microspheres to measure renal vessel diameters in the rat,
reported that angiotensin II infusion did not cause a reduction in
mean afferent arteriolar diameter, despite significant elevations
of systemic blood pressure. By direct observation of intrarenal
vessels in rats with postischemic hydronephrosis, Steinhausen
et al [61 found that angiotensin II infusions caused a 27% mean
reduction in afferent arteriolar diameter in one set of experi-
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Fig. 4. Casts of afferent arterioles from a
norepinephrine—treated rat with renal vessels
exposed to normal blood pressure (Group 4).
A is from the cortex and B is from the
juxtamedullary region. An intermittent and
focal constriction pattern is shown. (800x)
ments and no decrease in diameter in another set of experi-
ments. In more recent studies, Steinhausen et a! [7] observed
that severe afferent arteriolar constriction occurred during
angiotensin II infusion in the same experimental model, and
attributed this primarily to a direct vasoconstrictive action of
this agent. In other studies, data from isolated rat kidneys [11,
121 led one group of investigators to conclude that the primary
effect of angiotensin II was constriction of efferent—not af-
ferent—renal arterioles.
In other species, studies of the effects of angiotensin II on
renal hemodynamics have yielded more consistent results.
Experiments with isolated rabbit kidneys [131 suggested that
angiotensin II acted primarily upon efferent, not afferent arteri-
oles. Similar conclusions were drawn from studies on intact
kidneys in the cat [14, 151 and dog [16—18]. However, experi-
mental studies of individual microvessels in the kidney have
provided conflicting data. Click, Joyner and Gilmore [5], using
renal transplant preparations in hamsters, observed that direct
application of angiotensin II to individual vessels produced
significant constriction of afferent arterioles (comparable to that
found in efferent arterioles) in normotensive animals. In con-
trast, Edwards [19] found that only efferent—not afferent—
arterioles constricted in response to the addition of angiotensin
II to isolated microvessel preparations from the rabbit.
Studies with norepinephrine have also produced conflicting
results, although most evidence suggests that norepinephrine
has a direct rather than indirect vasoconstrictive action on
afferent arterioles. One set of micropuncture studies in the rat
[81 showed that norepinephrine infusion increased afferent
arteriolar resistance only when attended by increases in sys-
temic arterial pressure. However, micropuncture studies by
other investigators [20] led to the opposite conclusion—that
afferent rather than efferent arterioles responded directly to
norepinephrine infusions. In the isolated perfused rabbit kidney
[13], experiments suggested that norepinephrine acted princi-
pally upon afferent vessels. Direct application of norepineph-
rime to arterioles in renal transplant tissue in hamsters [5] and to
isolated microvessel preparations from rabbits [19] revealed
that afferent arterioles responded by significant vasoconstric-
tion.
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In view of the uncertainty about the effects of angiotensin II
and norepinephrine on renal afferent arterioles, especially in
studies in the rat, the present study was undertaken to examine
this problem by using a perfusion—fixation and vascular casting
technique, Vascular casts have been used successfully to study
changes in renal circulation under a variety of experimental
conditions [21, 23—25]. Moreover, measurements of vascular
casts by scanning electron microscopy have been found to
correlate reliably with morphometric data obtained from tissue
sections [23, 241, indicating that casts can be used with reason-
able confidence in making quantitative as well as qualitative
assessments. The vascular casting technique has certain advan-
tages over other methods (such as micropuncture techniques,
isolated kidney preparations, isolated microvesscls) in studying
the response of intrarenal vessels to angiotensin 11 and norepi-
nephrine. First, it affords observation of a large number of
individual afferent arterioles; second, it provides a view of the
distribution of constriction along the entire length of individual
arterioles; and third, it allows comparison of vessels in different
regions of the kidney (such as cortical vs. juxtamedullary
Fig. 5. Casts of afferent arterioles from a
saline—treated rat with renal vessels
perfusion—fixed at high pressure (Group 5). A
is from the cortex, and B is from the
juxtamedullary region. The vessels are of
uniform caliber and there is no evidence of
focal or diffuse constriction. (800x)
regions), It is interesting to note, however, that different
techniques produce a wide range of diameter measurements for
normal afferent arterioles in rats. Mean afferent arteriolar
diameter measurements in the renal cortex have been reported
to be approximately 20 microns using microsphere techniques
jl0J, 16 microns with freeze—substitution methods [231, and 8 to
9 microns by microscopic observation of vessels in hydrone-
phrotic kidneys 16, 71; mean diameters in the cortex were
approximately 15 microns in the present study.
By use of the vascular casting technique, the present study
established that angiotensin II and norepinephrine cause severe
constriction of afferent arterioles when there is a concurrent
rise in systemic and renal blood pressures (Groups 1 and 3).
Typically the constriction in both angiotensin lI-treated and
norepinephrinc—treated animals was focal and irregularly dis-
tributed along the length of the afferent arterioles (Figs. I and
3), a pattern earlier observed in vascular beds outside the
kidney 126, 271. It is worth noting that this pattern of focal
constriction was found in the juxtamedullary as well as the
cortical regions in both groups of vasopressor—treated animals.
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Fig. 6. Casts of afferent arterioles from a
saline—treated rat with renal vessels
perfusion—fixed at normal pressure (Group 6).
A is from the cortex, and B is from the
juxtamedullary region. Vessel calibers are
uniform in both A and B, with no evidence of
diffuse or localized constriction. (800x)
Table 2. Measurements for all afferent arteriolesa
N = 5 Length
Maximum
diameter
Minimum
diameter
Mean
diameter
Group 1 188.16 4.18 16.56 0.32 6.74 0.09" 11.01 0.16"
Group 2 197,96 5.08 16.73 0.32 7.18 0.16'-' 10.47 034b
Group 3 189.12 7.62 18.05 0.39 7.15 0.09" 11.82 0.33"
Group 4 195.98 7.12 18.22 0.19 6.93 0.10" 11.19 019"
Group 5 176.13 6.16 17.79 0.36 12.10 0.08 14.97 0.05
Group 6 184.99 5.88 18.42 0.02 13.04 0.12 15.63 0.14
a Allvalues are means expressed in microns saM; Means were obtained first by calculating means for 40 to 50 vessels from each rat, then using
these means to calculate a mean for each group of 5 rats
b Mean values significantly lower than corresponding means in Group 5 or Group 6 (P < 0.005, Bonferroni method.)
Quantitatively, the severe constriction of afferent arterioles in which were unconstricted or not as severely constricted as
Groups 1 and 3 was reflected in the significantly lower values other segments. Quantitatively, juxtamedullary and cortical
for minimum and mean diameters compared to those in Group arterioles showed similar degrees of constriction (Tables 3 and
5 or Group 6. Interestingly, maximum diameters in Groups 1 4) and did not differ significantly in any measured values except
and 3 were not significantly smaller than those in Groups 5 or 6, for length (juxtamedullary arterioles were longer). In general,
probably reflecting the fact that most vessels had segments all diameter measurements from angiotensin Il-treated rats
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Maximum Minimum Mean
Lengthc diameter diameter diameter
Group 1 173.22 4.21 16.29 0.28 6.64 0.06k' 10.80 0.18"
Group 2 177.77 4.48 16.17 0.33 7.01 0.15 10.08 0.35"
Group 3 174.04 5.58 17.61 0.33 7.14 0.05" 11.58 0.38k'
Group 4 180.56 3.37 17.77 0.19 6.80 0.11" 10.79 0.17"
Group 5 160.51 1.97 17.57 0.09 11.99 0.10 14.77 0.03
Group 6 167.93 4.94 18.05 0.25 12.89 0.12 15.33 0.16
were somewhat (but not significantly) smaller than those from
norepinephrine—treated animals; this suggests that the dose of
angiotensin 11 used in these experiments produced somewhat
greater vasoconstriction than did the dose of norepinephrine,
which may be reflected in the slightly higher MAPs in angio-
tensin Il-treated animals (Table 1). Nonetheless, the crucial
point is that both angiotensin II and norepinephrine produced
severe, focal constriction of afferent arterioles when pressure in
the renal circulation was elevated, and that the constriction was
similar quantitatively and qualitatively with both agents.
A second point established in these experiments is that
angiotensin 11 and norepinephrine produce severe affereni
arteriolar constriction when the renal vessels are not exposed to
elevated pressure (achieved by partial ligation of the aorta
above the renal arteries). Quantitatively and qualitatively, the
constriction of afferent arterioles in the vasopressor—treated
animals with normal renal pressures (Groups 2 and 4) was
similar to that observed in Groups I and 3. For example,
constriction in afferent arterioles from Groups 2 and 4 was
typically focal and irregular, a pattern that was found in the
cortical as well as the juxtamedullary region (Fig. 2 and 4).
Morphometric data from Group 2 were comparable to those
from its counterpart in Group 1, and likewise for Group 4
compared to Group 3. There were, moreover, no significant
quantitative differences between juxtamedullary and cortical
vessels (except that the former were longer) in Groups 2 and 4.
All of these data suggest that the afferent arteriolar constriction
observed and measured in Groups 2 and 4 cannot be attributed
principally to a pressure—induced autoregulatory response,
since these vessels were not exposed to increased pressure.
Experiments with Group 5 rats were carried out to determine
the effects of elevated perfusion—fixation pressures on afferent
arterioles in the absence of vasopressor infusion. Renal vessels
in this group were immediately perfused with fixative at 146.4
4.0 mm Hg—a perfusion pressure comparable to that used in
animals given angiotensin II and norepinephrinc infusions in
Groups 1 and 3. Vascular casts from Group S showed no
evidence of severe, focally distributed constriction of afferent
arterioles as was observed in Groups 1 and 3. However,
morphometric data from Group 5 revealed that values for
maximum, minimum, and mean arteriolar diameters were con-
sistently smaller when compared to those from normotensive
animals (Group 6), although the differences were not statisti-
cally significant. These figures suggest that elevation of renal
pci-fusion—fixation pressure itself induced a minor degree of
afferent constriction, which is probably best explained as a
rapid autoregulatory response of afferent arterioles to elevated
pressure before undergoing complete fixation with glutaral-
dehyde.
The morphometric data from Group 5 lead to the idea that
elevated renal perfusion—fixation pressure per se may have
made a contribution to the arteriolar constriction observed and
measured in Groups 1 and 3. Several points related to this idea
merit consideration, however. First, the magnitude of constric-
tion occurring in Groups I and 3 was far greater than that
attributable to fixation at increased pressure alone. Second, the
distinctive pattern of focal and irregular constriction observed
in Groups 1 and 3 cannot be ascribed to a pressure—induced
response, since this constriction pattern was not observed in
arterioles of rats from Group 5. Third, the diameter measure-
ments in Groups I and 3 were not significantly smaller than
those in Groups 2 and 4, indicating that elevation of perfusion
pressure was not a major factor in the arteriolar constriction
seen in the vasopressor—treated animals.
in conclusion, these studies indicate that both angiotensin II
and norepinephrine produce severe, focal constriction of af-
ferent arterioles in the rat kidney; that this constriction occurs
in all regions of the kidney; and that the major part of this
constriction is not attributable to a pressure—induced (myo-
genie) autoregulatory response in the renal vasculature. One
likely explanation for the reduction in afferent arteriole diame-
ter seen in the experiments is a direct constrictive action of
angiotensin II and norepinephrine; however, intrinsic autoreg-
ulatory mechanisms such as tubuloglomerular feedback must
also be considered as possible contributors to afferent vasocon-
striction. For example, previous experiments in dogs [18]
suggested that angiotensin II activated tubuloglomerular feed-
back mechanisms by raising GFR and distal tubular flow rate,
thereby indirectly stimulating an increase in afferent resistance.
However, recent studies in rats suggest a less important role for
tubuloglomerular feedback. By direct observation of intrarenal
vessels, Steinhausen et al [71 showed that acute intravenous
injections of angiotensin II caused severe constriction of af-
ferent arterioles in rat kidneys with postischemic hydronephro-
sis—an experimental model in which tubular continuity has
been interrupted and tubuloglomerular feedback mechanisms
are effectively eliminated. Although this evidence suggests that
tubuloglomerular feedback does not play a major role in angi-
otensin lI-induced afferent constriction, it remains possible in
the present study that intrinsic feedback mechanisms could
have contributed to reduction in afferent arteriolar diameter,
because renal tubular structures were intact.
'On a final note, brief mention should be made of the doses of
vasopressors used in the present study and in previous work.
The experiments described here used rather high phar-
macologic doses of angiotensin 11(0.2 rg/kg/min) and norepi-
nephrine (2.0 /Lg/kg/min). These doses were chosen intention-
ally to correspond to those administered in earlier studies of the
effects of infused pressor agents on intrarenal circulation in
rats; the intent was to facilitate comparison with previous work.
In earlier studies, infusion rates for angiotensin II ranged from
0.05 to 0.4 .tg/kg/min 16—101 and for norepinephrine from 2.0 to
Table 3 Measurements of afferent arterioles from the mid and outer
eortexa
a All values are means expressed in microns sru; Means were
obtained first by calculating means for 40 to 50 vessels from each rat,
then using these means to calculate a mean for each group of five rats.
b Mean values significantly lower than corresponding means in Group
5 or Group 6 (P < 0.005, Bonferroni method)
C Mean values significantly lower than corresponding means in jux-
tamedullary arterioles in all groups (P < 0.005, t-test)
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Table 4. Measurements of afferent arterioles from the juxtamedullary regiona
Lengthc
Maximum
diameter
Minimum
diameter
Mean
diameter
Group 1
Group 2
Group 3
Group 4
252.48 8.15
268.64 11.49
238.23 12.38
245.11 5.34
18.56 0.53
18.63 0.32
19.36 0.82
19.71 0.13
7.14 0.29"
7.74 O.23
7.15 0.18"
7.28 0.16"
11.74 019b
11.74 033b
12.55 0.50"
12.43 0.11"
Group 5 255.10 9.31 18.91 0.40 12.72 0.19 16.07 0.23
Group 6 250.43 7.05 19.81 0.33 13.59 0.19 16.77 0.20
a All values are means expressed in microns SEM; Means were obtained first by calculating means for 40 to 50 vessels from each rat, then using
these means to calculate a mean for each group of five rats
"Mean values significantly lower than corresponding means in Group 5 or Group 6 (P < 0.005, Bonferroni method)
"Mean values significantly higher than corresponding means in cortical arterioles in all groups (P < 0.005, 1-test)
4.0 jg/kmin [8, 201. In all of these experiments (including the
present study), infusion rates undoubtedly created non-physi-
ologic plasma levels of these agents, and it must be considered
that the observed changes in vessel diameter and/or resistance
probably represent exaggerations of what occurs in most
pathophysiologic states. Hence, although this study effectively
showed that angiotensin II and norepinephrine infusions pro-
duced severe reductions in afferent arteriolar diameter, it is
likely that less dramatic changes in vessel diameter occur in
various pathophysiologic states with lower plasma concentra-
tions of these substances.
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